Chiu H-Y, Wang T-S, Chan C-C, Lin S-J, Tsai T-F. Risk Factor Analysis for the Immunogenicity of Adalimumab Associated with Decreased Clinical Response in Chinese Patients with Psoriasis. Acta Derm Venereol [Internet]. 2015 Feb. 27 [cited 2024 Nov. 27];95(6):711-6. Available from: https://medicaljournalssweden.se/actadv/article/view/5826